DE3174765D1 - High titer production of hepatitis a virus - Google Patents

High titer production of hepatitis a virus

Info

Publication number
DE3174765D1
DE3174765D1 DE8181401172T DE3174765T DE3174765D1 DE 3174765 D1 DE3174765 D1 DE 3174765D1 DE 8181401172 T DE8181401172 T DE 8181401172T DE 3174765 T DE3174765 T DE 3174765T DE 3174765 D1 DE3174765 D1 DE 3174765D1
Authority
DE
Germany
Prior art keywords
hepatitis
virus
high titer
titer production
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181401172T
Other languages
German (de)
English (en)
Inventor
Henry Z Markus
William J Mcaleer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3174765D1 publication Critical patent/DE3174765D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8181401172T 1980-07-23 1981-07-22 High titer production of hepatitis a virus Expired DE3174765D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/171,621 US4301249A (en) 1980-07-23 1980-07-23 High titer production of hepatitis A virus

Publications (1)

Publication Number Publication Date
DE3174765D1 true DE3174765D1 (en) 1986-07-10

Family

ID=22624494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181401172T Expired DE3174765D1 (en) 1980-07-23 1981-07-22 High titer production of hepatitis a virus

Country Status (11)

Country Link
US (1) US4301249A (https=)
EP (1) EP0044793B1 (https=)
JP (1) JPS5753410A (https=)
AT (1) ATE20250T1 (https=)
CA (1) CA1187413A (https=)
DE (1) DE3174765D1 (https=)
DK (1) DK326781A (https=)
ES (1) ES504199A0 (https=)
GR (1) GR74594B (https=)
IE (1) IE51454B1 (https=)
PT (1) PT73371B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
WO1992010564A1 (en) * 1990-12-13 1992-06-25 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
CA2480121C (en) * 2002-03-27 2012-02-28 Immunex Corporation Methods for increasing polypeptide production
EP2067856A4 (en) * 2006-09-26 2012-11-07 Toyo Boseki METHOD FOR PROLIFERATING A HEPATITIS VIRUS, HOLLOW FIBER FOR CULTURING HEPATITIS VIRUS-INFECTED CELLS AND USE THEREOF
CN101688186A (zh) * 2007-05-04 2010-03-31 巴克斯特国际公司 用于病毒增殖的两阶段温度分布
JP5692688B2 (ja) * 2008-06-26 2015-04-01 東洋紡株式会社 感染性ｃ型肝炎ウイルス粒子の製造方法、およびその利用
CA2829774C (en) 2011-03-14 2019-09-24 National Research Council Of Canada Method of viral production in cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
US4087327A (en) * 1976-04-12 1978-05-02 Monsanto Company Mammalion cell culture process
FR2398504A1 (fr) 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen

Also Published As

Publication number Publication date
IE51454B1 (en) 1986-12-24
ES8205016A1 (es) 1982-05-16
DK326781A (da) 1982-01-24
PT73371A (en) 1981-08-01
CA1187413A (en) 1985-05-21
IE811655L (en) 1982-01-23
PT73371B (en) 1983-06-15
ES504199A0 (es) 1982-05-16
JPS5753410A (en) 1982-03-30
EP0044793B1 (en) 1986-06-04
EP0044793A2 (en) 1982-01-27
US4301249A (en) 1981-11-17
ATE20250T1 (de) 1986-06-15
GR74594B (https=) 1984-06-29
EP0044793A3 (en) 1983-01-05

Similar Documents

Publication Publication Date Title
DE3174765D1 (en) High titer production of hepatitis a virus
IE882407L (en) Purifying hepatitis a virus
DE3260046D1 (en) Method of producing hepatitis b surface antigen
ES445716A1 (es) Procedimiento para preparar n-acil-l-metionina opticamente pura.
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
ATE127526T1 (de) Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.
IE781315L (en) Virus cultivation
ES2028968T3 (es) Sistema de gobierno de la produccion.
EP0320777A3 (en) A novel approach to produce natural vitamin e making use of an asymmetric synthesis
ATE117462T1 (de) Infrarot-strahlungsquelle und verfahren zur herstellung.
ATE86962T1 (de) Verfahren zur herstellung 1,4-disubstituierter 2- butene.
GR880100042A (el) Παραγωγα πυλοκαρπινης
SU1692147A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура cn 564
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler
GB8622883D0 (en) Expression of hepatitis b viral antigens
JPS5396821A (en) Diaphragm for speaker

Legal Events

Date Code Title Description
8364 No opposition during term of opposition